SCHEMBL13233282

SCHEMBL13233282

SCOC(OCS)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
SCN1A P35498 3/20 0.36
SCN2A Q99250 3/20 0.36
SCN3A Q9NY46 3/20 0.36
TSHR P16473 2/20 0.36
HRH1 P35367 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
CHRM1 P11229 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36
SLC6A2 P23975 1/20 0.36
HRH2 P25021 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28474051 0.75 CYP2D6 (0.41) HTR2ATAAR1SCN1ASCN2ASCN3A
SCHEMBL27191 0.75 ACHE (0.47) HTR2ASCN1ASCN2ASCN3ATSHR
SCHEMBL4384773 0.73 HTT (0.44) HTR2ATAAR1SCN1ASCN2ASCN3A
SCHEMBL11100946 0.73 SLC6A2 (0.50) TSHRCYP1A2CYP2D6SLC6A2SLC6A4
SCHEMBL3092744 0.71 TAAR1 (0.41) HTR2ATAAR1SCN1ASCN2ASCN3A
Bromide SCHEMBL30327209 0.71 ACHE (0.44) HTR2ASCN1ASCN2ASCN3ATSHR
SCHEMBL10458379 0.71 TAAR1 (0.41) HTR2ATAAR1SCN1ASCN2ASCN3A
SCHEMBL7120235 0.71 ALDH1A1 (0.46) HTR2ASCN1ASCN2ASCN3ATSHR
SCHEMBL16767872 0.71 HRH1 (0.48) HTR2ATAAR1TSHRHRH1CYP1A2
SCHEMBL8568338 0.71 HTR2A (0.36) HTR2ATAAR1SCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100203115-A1 ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100203115-A1 ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES CD44, RCC1, CD63 HTR2A 3628/4885TAAR1 2540/4885SCN1A 3729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.